Report Detail

Request for Sample of this report

Other Global Acromegaly Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4600247
    • |
  • 02 July, 2024
    • |
  • Global
    • |
  • 111 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Acromegaly market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Acromegaly is a hormonal disorder that develops when your pituitary gland produces too much growth hormone during adulthood. When this happens, your bones increase in size, including those of your hands, feet and face. Acromegalyusually affects middle-aged adults.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Acromegaly industry chain, the market status of Hospitals (Somatostatin Analogues, Dopamine Agonists), Clinics (Somatostatin Analogues, Dopamine Agonists), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Acromegaly.
Regionally, the report analyzes the Acromegaly markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Acromegaly market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Acromegaly market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Acromegaly industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Somatostatin Analogues, Dopamine Agonists).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Acromegaly market.
Regional Analysis: The report involves examining the Acromegaly market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Acromegaly market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Acromegaly:
Company Analysis: Report covers individual Acromegaly players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Acromegaly This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Acromegaly. It assesses the current state, advancements, and potential future developments in Acromegaly areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Acromegaly market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Acromegaly market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Somatostatin Analogues
Dopamine Agonists
Growth Hormone Receptor Antagonists
Other
Market segment by Application
Hospitals
Clinics
Market segment by players, this report covers
Novartis
Aegis Therapeutics
Chiasma
Crinetics Pharmaceuticals
Daewoong Pharmaceutical
Peptron
Silence Therapeutics
Strongbridge Biopharma
Amryt Pharma
Foresee Pharmaceuticals
Glide Pharmaceutical
Ionis Pharmaceuticals
Ipsen
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Acromegaly product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Acromegaly, with revenue, gross margin and global market share of Acromegaly from 2019 to 2024.
Chapter 3, the Acromegaly competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Acromegaly market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Acromegaly.
Chapter 13, to describe Acromegaly research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Acromegaly
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Acromegaly by Type
    • 1.3.1 Overview: Global Acromegaly Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Acromegaly Consumption Value Market Share by Type in 2023
    • 1.3.3 Somatostatin Analogues
    • 1.3.4 Dopamine Agonists
    • 1.3.5 Growth Hormone Receptor Antagonists
    • 1.3.6 Other
  • 1.4 Global Acromegaly Market by Application
    • 1.4.1 Overview: Global Acromegaly Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
  • 1.5 Global Acromegaly Market Size & Forecast
  • 1.6 Global Acromegaly Market Size and Forecast by Region
    • 1.6.1 Global Acromegaly Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Acromegaly Market Size by Region, (2019-2030)
    • 1.6.3 North America Acromegaly Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Acromegaly Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Acromegaly Market Size and Prospect (2019-2030)
    • 1.6.6 South America Acromegaly Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Acromegaly Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Novartis
    • 2.1.1 Novartis Details
    • 2.1.2 Novartis Major Business
    • 2.1.3 Novartis Acromegaly Product and Solutions
    • 2.1.4 Novartis Acromegaly Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Novartis Recent Developments and Future Plans
  • 2.2 Aegis Therapeutics
    • 2.2.1 Aegis Therapeutics Details
    • 2.2.2 Aegis Therapeutics Major Business
    • 2.2.3 Aegis Therapeutics Acromegaly Product and Solutions
    • 2.2.4 Aegis Therapeutics Acromegaly Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Aegis Therapeutics Recent Developments and Future Plans
  • 2.3 Chiasma
    • 2.3.1 Chiasma Details
    • 2.3.2 Chiasma Major Business
    • 2.3.3 Chiasma Acromegaly Product and Solutions
    • 2.3.4 Chiasma Acromegaly Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Chiasma Recent Developments and Future Plans
  • 2.4 Crinetics Pharmaceuticals
    • 2.4.1 Crinetics Pharmaceuticals Details
    • 2.4.2 Crinetics Pharmaceuticals Major Business
    • 2.4.3 Crinetics Pharmaceuticals Acromegaly Product and Solutions
    • 2.4.4 Crinetics Pharmaceuticals Acromegaly Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Crinetics Pharmaceuticals Recent Developments and Future Plans
  • 2.5 Daewoong Pharmaceutical
    • 2.5.1 Daewoong Pharmaceutical Details
    • 2.5.2 Daewoong Pharmaceutical Major Business
    • 2.5.3 Daewoong Pharmaceutical Acromegaly Product and Solutions
    • 2.5.4 Daewoong Pharmaceutical Acromegaly Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Daewoong Pharmaceutical Recent Developments and Future Plans
  • 2.6 Peptron
    • 2.6.1 Peptron Details
    • 2.6.2 Peptron Major Business
    • 2.6.3 Peptron Acromegaly Product and Solutions
    • 2.6.4 Peptron Acromegaly Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Peptron Recent Developments and Future Plans
  • 2.7 Silence Therapeutics
    • 2.7.1 Silence Therapeutics Details
    • 2.7.2 Silence Therapeutics Major Business
    • 2.7.3 Silence Therapeutics Acromegaly Product and Solutions
    • 2.7.4 Silence Therapeutics Acromegaly Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Silence Therapeutics Recent Developments and Future Plans
  • 2.8 Strongbridge Biopharma
    • 2.8.1 Strongbridge Biopharma Details
    • 2.8.2 Strongbridge Biopharma Major Business
    • 2.8.3 Strongbridge Biopharma Acromegaly Product and Solutions
    • 2.8.4 Strongbridge Biopharma Acromegaly Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Strongbridge Biopharma Recent Developments and Future Plans
  • 2.9 Amryt Pharma
    • 2.9.1 Amryt Pharma Details
    • 2.9.2 Amryt Pharma Major Business
    • 2.9.3 Amryt Pharma Acromegaly Product and Solutions
    • 2.9.4 Amryt Pharma Acromegaly Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Amryt Pharma Recent Developments and Future Plans
  • 2.10 Foresee Pharmaceuticals
    • 2.10.1 Foresee Pharmaceuticals Details
    • 2.10.2 Foresee Pharmaceuticals Major Business
    • 2.10.3 Foresee Pharmaceuticals Acromegaly Product and Solutions
    • 2.10.4 Foresee Pharmaceuticals Acromegaly Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Foresee Pharmaceuticals Recent Developments and Future Plans
  • 2.11 Glide Pharmaceutical
    • 2.11.1 Glide Pharmaceutical Details
    • 2.11.2 Glide Pharmaceutical Major Business
    • 2.11.3 Glide Pharmaceutical Acromegaly Product and Solutions
    • 2.11.4 Glide Pharmaceutical Acromegaly Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Glide Pharmaceutical Recent Developments and Future Plans
  • 2.12 Ionis Pharmaceuticals
    • 2.12.1 Ionis Pharmaceuticals Details
    • 2.12.2 Ionis Pharmaceuticals Major Business
    • 2.12.3 Ionis Pharmaceuticals Acromegaly Product and Solutions
    • 2.12.4 Ionis Pharmaceuticals Acromegaly Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Ionis Pharmaceuticals Recent Developments and Future Plans
  • 2.13 Ipsen
    • 2.13.1 Ipsen Details
    • 2.13.2 Ipsen Major Business
    • 2.13.3 Ipsen Acromegaly Product and Solutions
    • 2.13.4 Ipsen Acromegaly Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Ipsen Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Acromegaly Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Acromegaly by Company Revenue
    • 3.2.2 Top 3 Acromegaly Players Market Share in 2023
    • 3.2.3 Top 6 Acromegaly Players Market Share in 2023
  • 3.3 Acromegaly Market: Overall Company Footprint Analysis
    • 3.3.1 Acromegaly Market: Region Footprint
    • 3.3.2 Acromegaly Market: Company Product Type Footprint
    • 3.3.3 Acromegaly Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Acromegaly Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Acromegaly Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Acromegaly Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Acromegaly Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Acromegaly Consumption Value by Type (2019-2030)
  • 6.2 North America Acromegaly Consumption Value by Application (2019-2030)
  • 6.3 North America Acromegaly Market Size by Country
    • 6.3.1 North America Acromegaly Consumption Value by Country (2019-2030)
    • 6.3.2 United States Acromegaly Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Acromegaly Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Acromegaly Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Acromegaly Consumption Value by Type (2019-2030)
  • 7.2 Europe Acromegaly Consumption Value by Application (2019-2030)
  • 7.3 Europe Acromegaly Market Size by Country
    • 7.3.1 Europe Acromegaly Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Acromegaly Market Size and Forecast (2019-2030)
    • 7.3.3 France Acromegaly Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Acromegaly Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Acromegaly Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Acromegaly Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Acromegaly Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Acromegaly Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Acromegaly Market Size by Region
    • 8.3.1 Asia-Pacific Acromegaly Consumption Value by Region (2019-2030)
    • 8.3.2 China Acromegaly Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Acromegaly Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Acromegaly Market Size and Forecast (2019-2030)
    • 8.3.5 India Acromegaly Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Acromegaly Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Acromegaly Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Acromegaly Consumption Value by Type (2019-2030)
  • 9.2 South America Acromegaly Consumption Value by Application (2019-2030)
  • 9.3 South America Acromegaly Market Size by Country
    • 9.3.1 South America Acromegaly Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Acromegaly Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Acromegaly Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Acromegaly Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Acromegaly Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Acromegaly Market Size by Country
    • 10.3.1 Middle East & Africa Acromegaly Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Acromegaly Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Acromegaly Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Acromegaly Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Acromegaly Market Drivers
  • 11.2 Acromegaly Market Restraints
  • 11.3 Acromegaly Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Acromegaly Industry Chain
  • 12.2 Acromegaly Upstream Analysis
  • 12.3 Acromegaly Midstream Analysis
  • 12.4 Acromegaly Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Acromegaly. Industry analysis & Market Report on Acromegaly is a syndicated market report, published as Global Acromegaly Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Acromegaly market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,634.36
    		3,951.54
    		5,268.72
    		3,132.00
    		4,698.00
    		6,264.00
    		494,682.00
    		742,023.00
    		989,364.00
    		291,380.40
    		437,070.60
    		582,760.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo